Life Biosciences Announces Publication in Cell Demonstrating Therapeutic...
BOSTON, April 22, 2021 — Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced the publication of preclinical research demonstrating clinical benefit of...
View ArticleLife Biosciences Appoints Seasoned Biopharma Executive Jerry McLaughlin as CEO
Dr. Mehmood Khan to remain Executive Chairman BOSTON, July 1, 2021 — Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced that the Company’s Board of...
View ArticleLife Biosciences Receives Translational Research Funding from Alzheimer’s...
BOSTON, Sept. 28, 2021 — Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, today announced translational research funding from the...
View ArticleLife Biosciences, Leading Developer of Therapeutics for Aging-Related...
Announces Bill Sullivan as Chief Financial Officer BOSTON, Jan. 5, 2022 — Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, today announced...
View ArticleLife Biosciences to Present at Longevity Leaders World Congress 2022
BOSTON, April 14, 2022 — Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, today announced that Jerry McLaughlin, Chief Executive Officer,...
View ArticleLife Biosciences CEO Jerry McLaughlin to Speak at Roadmap to Healthy...
BOSTON, February 9, 2023 — Life Biosciences, a pioneering biotech company developing therapeutics that target the biology of aging, today announced that Jerry McLaughlin, Chief Executive Officer, will...
View ArticleLife Biosciences Appoints Sharon Rosenzweig-Lipson, PhD as Chief Scientific...
Dr. Rosenzweig-Lipson brings decades of experience in R&D strategy and clinical development as Life Biosciences advances therapeutics that target the biology of aging BOSTON, February 13, 2023 –...
View ArticleLife Biosciences Presents Groundbreaking Data at ARVO Demonstrating...
Data in a nonhuman primate model of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) demonstrates the ability to restore visual function after delivery of a novel gene therapy BOSTON, April 23,...
View ArticleClik here to view.
Life Biosciences and Forge Biologics Announce cGMP Manufacturing Partnership...
Forge to provide cGMP manufacturing and development services for Life Biosciences’ novel adeno-associated virus (AAV) gene therapy platform for aging-related diseases, including in ophthalmic...
View ArticleLife Biosciences Expands Team with the Appointment of Ming Yang, Ph.D., as...
Boston, MA, May 23, 2023 – Life Biosciences (“Life Bio”), a biotechnology company advancing innovative cellular rejuvenation platforms to reverse diseases of aging and injury and ultimately restore...
View Article